Synthesis and structure-activity relationship of 2-arylamino-4-aryl-pyrimidines as potent PAK1 inhibitors

被引：13

作者：

Xu, Yong ^{[1
]}

Foulks, Jason M. ^{[1
]}

Clifford, Adrianne ^{[1
]}

Brenning, Benjamin ^{[1
]}

Lai, Shuping ^{[1
]}

Luo, Bai ^{[1
]}

Parnell, K. Mark ^{[1
]}

Merx, Shannon ^{[1
]}

McCullar, Michael V. ^{[1
]}

Kanner, Steven B. ^{[1
]}

Ho, Koc-Kan ^{[1
]}

机构：

[1] Astex Pharmaceut Inc, Dublin, CA 94568 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2013年 / 23卷 / 14期

关键词：

PAK1; kinase; 2-Arylamino-4-aryl-pyrimidines; Colon cancer; Pak1; inhibitor; Bioisostere; CANCER-CELLS; P21-ACTIVATED KINASE; EXPRESSION; TARGET; AMPLIFICATION; MECHANISM; CARCINOMA; REVEALS;

D O I：

10.1016/j.bmcl.2013.05.059

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

2-Arylamino-4-aryl-pyrimidines were found to be potent inhibitors of PAK1 kinase. The synthesis and SAR are described. The incorporation of a bromide at the 5-position of the pyrimidine core and in combination with a 1,2-dimethylpiperazine pendant domain yielded a lead compound with potent PAK1 inhibition and anti-proliferative activity in various colon cancer cell lines. (C) 2013 Elsevier Ltd. All rights reserved.

引用

页码：4072 / 4075

页数：4

共 50 条

[1] Design, synthesis, and structure-activity relationship of novel RIPK2 inhibitors
Wu, Shuwei
Xu, Liben
Wang, Xinhui
Yang, Qing
Wang, Jingrui
He, Sudan
Zhang, Xiaohu
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 75
[2] Discovery of indolin-2-one derivatives as potent PAK4 inhibitors: Structure-activity relationship analysis, biological evaluation and molecular docking study
Guo, Jing
Zhu, Mingyue
Wu, Tianxiao
Hao, Chenzhou
Wang, Kai
Yan, Zizheng
Huang, Wanxu
Wang, Jian
Zhao, Dongmei
Cheng, Maosheng
BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (13) : 3500 - 3511
[3] Design, Synthesis and Structure-Activity Relationship Studies of Novel Survivin Inhibitors with Potent Anti-Proliferative Properties
Xiao, Min
Wang, Jin
Lin, Zongtao
Lu, Yan
Li, Zhenmei
White, Stephen W.
Miller, Duane D.
Li, Wei
PLOS ONE, 2015, 10 (06):
[4] Synthesis and structure-activity relationship of aminopyrimidine IKK2 inhibitors
Bingham, Alistair H.
Davenport, Richard J.
Fosbeary, Richard
Gowers, Lewis
Knight, Roland L.
Lowe, Christopher
Owen, David A.
Parry, David M.
Pitt, Will R.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (12) : 3622 - 3627
[5] Synthesis, antitumor,activity, and structure-activity relationship study of trihydroxylated 2,4,6-triphenyl pyridines as potent and selective topoisomerase II inhibitors
Karki, Radha
Park, Chanmi
Jun, Kyu-Yeon
Jee, Jun-Goo
Lee, Jun-Ho
Thapa, Pritam
Kadayat, Tara Man
Kwon, Youngjoo
Lee, Eung-Seok
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 84 : 555 - 565
[6] Synthesis and structure-activity relationship studies of α-naphthoflavone derivatives as CYP1B1 inhibitors
Dong, Jinyun
Wang, Zengtao
Cui, Jiahua
Meng, Qingqing
Li, Shaoshun
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 187
[7] Synthesis, Structure-Activity Relationship Studies, and X-ray Crystallographic Analysis of Arylsulfonamides as Potent Carbonic Anhydrase Inhibitors
Gitto, Rosaria
Damiano, Francesca M.
Mader, Pavel
De Luca, Laura
Ferro, Stefania
Supuran, Claudiu T.
Vullo, Daniela
Brynda, Jiri
Rezacova, Pavlina
Chimirri, Alba
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (08) : 3891 - 3899
[8] Design, synthesis and structure-activity relationship of 1,8-naphthalimide derivatives as highly potent hCYP1B1 inhibitors
Wei, Yueyue
Xiong, Yuan
Liao, Qingyi
Yang, Ya
Tian, Tian
Guo, Xiqian
Dong, Sanfeng
Zhu, Jianming
Zhang, Yong
Li, Bo
Xu, Zhijian
Zhu, Weiliang
Ge, Guangbo
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 107
[9] Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: Part 1
Ohtawa, Masaki
Yamazaki, Hiroyuki
Ohte, Satoshi
Matsuda, Daisuke
Ohshiro, Taichi
Rudel, Lawrence L.
Omura, Satoshi
Tomoda, Hiroshi
Nagamitsu, Tohru
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (05) : 1285 - 1287
[10] Synthesis and structure-activity relationships of novel, potent, orally active hypoxia-inducible factor-1 inhibitors
Nagao, Satoshi
Yamane, Yoshinobu
Funasaka, Setsuo
Tanaka, Keigo
Miyazaki, Kazuki
Kotake, Yoshihiko
Kamata, Jun-ichi
Watanabe-Miyano, Saori
Toyama, Osamu
Ozawa, Yoichi
Mizui, Yoshiharu
Okamoto, Kiyoshi
Ito, Daisuke
BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (19) : 5513 - 5529

← 1 2 3 4 5 →